Summary by Moomoo AI
VIA BIOTECHNOLOGY HOLDINGS GROUP WILL HOLD ITS ANNUAL GENERAL MEETING ON 26 JUNE 2024 AT MEETING ROOM A615, 735 ZIPING ROAD, ZHOUPU TOWN, PUDONG NEW DISTRICT, SHANGHAI, CHINA. The Meeting will consider a number of ordinary resolutions, including the review and adoption of the audited consolidated financial statements and related reports for the year ended 31 December 2023, the re-election of such directors as Delin, Wang Fui, Fu Lei and Li Xingrong, and authorizing the Board to determine the remuneration of directors. In addition, the meeting will consider the renewal of EY Accountants as auditor and determine remuneration, and discuss general mandates for the issuance and repurchase of shares. The Special Resolution includes the approval and adoption of the third revised and recast of the Company's Articles of Association and Conditions. Shareholders will have the right to appoint representatives to attend the general meeting and vote, and the registration of the Company's shares will be suspended from 21 to 26 June 2024.